Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
Whitepaper
– Cell and Gene Therapies (CGTs) offer significant potential for treating cancers and rare diseases.
– Autologous and Allogeneic therapy types and the CGT value chain anchor the whitepaper.
– Coverage includes expedited programs for accelerating CGT launches and commercialization challenges.
– Hexaware shares its experience across the full CGT value chain.
Cell and Gene Therapies (CGTs) are revolutionizing the Life Sciences industry, offering groundbreaking potential for treating or even curing cancers and rare diseases. With the CGT market poised to experience unprecedented growth, understanding this transformative field is essential.
This whitepaper provides a comprehensive overview of the rapidly evolving field of cell and gene therapy. It discusses the following:
Uncover the rapid growth, challenges, and transformative capabilities of CGTs in this whitepaper.
Read our whitepaper to learn more.
Get the Resource
Fill out the form below to gain instant access to our exclusive content.